Combination of memantine and vitamin D prevents axon degeneration induced by amyloid-beta and glutamate

Neurobiology of Aging

Volumn 35, Issue 2, 2014, Pages 331-335

  Annweiler, Cédric ^a,b,c,d   Brugg, Bernard ^e   Peyrin, Jean Michel ^e   Bartha, Robert ^d   Beauchet, Olivier ^a,b,c  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b University Memory Clinic   (France)

^c UNIVERSITÉ D'ANGERS   (France)

^d ROBARTS RESEARCH INSTITUTE   (Canada)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

Alzheimer's disease; Amyloid beta; Glutamate; Memantine; Neuroprotection; Vitamin D

Indexed keywords

AMYLOID BETA PROTEIN; CALCITRIOL; GLUTAMIC ACID; MEMANTINE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL CULTURE; COGNITION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG POTENTIATION; EMBRYO; MICROFLUIDICS; MOUSE; NERVE FIBER; NERVE FIBER DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ALZHEIMER'S DISEASE; AMYLOID-BETA; GLUTAMATE; MEMANTINE; NEUROPROTECTION; VITAMIN D;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; AXONS; CELLS, CULTURED; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; MEMANTINE; MICE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; VITAMIN D;

EID: 84887238966     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.07.029     Document Type: Article

References (29)

1. Annweiler C., Beauchet O. Possibility of a new anti-Alzheimer's disease pharmaceutical composition combining memantine and vitamin D. Drugs. Aging 2012, 29:81-91.
2. Annweiler C., Schott A.M., Berrut G., Chauviré V., Le Gall D., Inzitari M., Beauchet O. Vitamin D and ageing: neurological issues. Neuropsychobiology 2010, 62:139-150.
3. Annweiler C., Herrmann F.R., Fantino B., Brugg B., Beauchet O. Effectiveness of the combination of memantine plus vitamin D on cognition in patients with Alzheimer disease: a pre-post pilot study. Cogn. Behav. Neurol. 2012, 25:121-127.
4. Benes F.M., Farol P.A., Majocha R.E., Marotta C.A., Bird E.D. Evidence for axonal loss in regions occupied by senile plaques in Alzheimer cortex. Neuroscience 1991, 42:651-660.
5. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am. J. Clin. Nutr. 2006, 84:18-28.
6. Brewer L.D., Thibault V., Chen K.C., Langub M.C., Landfield P.W., Porter N.M. Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J.Neurosci. 2001, 21:98-108.
7. Brown J., Bianco J.I., McGrath J.J., Eyles D.W. 1,25-Dihydroxyvitamin D-3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci. Lett. 2003, 343:139-143.
8. Hiruma H., Katakura T., Takahashi S., Ichikawa T., Kawakami T. Glutamate and amyloid beta-protein rapidly inhibit fast axonal transport in cultured rat hippocampal neurons by different mechanisms. J.Neurosci. 2003, 23:8967-8977.
9. Ibi M., Sawada H., Nakanishi M., Kume T., Katsuki H., Kaneko S., Shimohama S., Akaike A. Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology 2001, 40:761-771.
10. Kalueff A.V., Tuohimaa P. Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr. Opin. Clin. Nutr. Metab. Care 2007, 10:12-19.
11. Kilinc D., Peyrin J.M., Soubeyre V., Magnifico S., Saias L., Viovy J.L., Brugg B. Wallerian-like degeneration of central neurons after synchronized and geometrically registered mass axotomy in a three-compartmental microfluidic chip. Neurotox. Res. 2011, 19:149-161.
12. Luo L., O'Leary D.D. Axon retraction and degeneration in development and disease. Annu. Rev. Neurosci. 2005, 28:127-156.
13. Martinez-Coria H., Green K.N., Billings L.M., Kitazawa M., Albrecht M., Rammes G., Parsons C.G., Gupta S., Banerjee P., LaFerla F.M. Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice. Am. J. Pathol. 2010, 176:870-880.
14. Masoumi A., Goldenson B., Ghirmai S., Avagyan H., Zaghi J., Abel K., Zheng X., Espinosa-Jeffrey A., Mahanian M., Liu P.T., Hewison M., Mizwickie M., Cashman J., Fiala M. 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. J.Alzheimers. Dis. 2009, 17:703-717.
15. McShane R., Areosa Sastre A., Minakaran N. Memantine for dementia. Cochrane. Database. Syst. Rev. 2006, CD003154.
16. Miguel-Hidalgo J.J., Alvarez X.A., Cacabelos R., Quack G. Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40). Brain. Res. 2002, 958:210-221.
17. Molnár Z., Soós K., Lengyel I., Penke B., Szegedi V., Budai D. Enhancement of NMDA responses by beta-amyloid peptides in the hippocampus invivo. Neuroreport 2004, 15:1649-1652.
18. Moore M.E., Piazza A., McCartney Y., Lynch M.A. Evidence that vitamin D3 reverses age-related inflammatory changes in the rat hippocampus. Biochem. Soc. Trans. 2005, 33:573-577.
19. Obradovic D., Gronemeyer H., Lutz B., Rein T. Cross-talk of vitamin D and glucocorticoids in hippocampal cells. Neurochem. 2006, 96:500-509.
20. Parsons C.G., Stoffler A., Danysz W. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system-too little activation is bad, too much is even worse. Neuropharmacology 2007, 53:699-723.
21. Peyrin J.M., Deleglise B., Saias L., Vignes M., Gougis P., Magnifico S., Betuing S., Pietri M., Caboche J., Vanhoutte P., Viovy J.L., Brugg B. Axon diodes for the reconstruction of oriented neuronal networks in microfluidic chambers. Lab. Chip 2011, 11:3663-3673.
22. Rosales-Corral S., Acuna-Castroviejo D., Tan D.X., López-Armas G., Cruz-Ramos J., Munoz R., Melnikov V.G., Manchester L.C., Reiter R.J. Accumulation of exogenous amyloid-beta peptide in hippocampal mitochondria causes their dysfunction: a protective role for melatonin. Oxid. Med. Cell. Longev. 2012, 2012:8436-8449.
23. Smith K.D., Kallhoff V., Zheng H., Pautler R.G. Invivo axonal transport rates decrease in a mouse model of Alzheimer's disease. Neuroimage 2007, 35:1401-1408.
24. Sun S.W., Campbell B., Carrick D., Liang H.F. Using DTI for non-invasive evaluation of axonal damage caused by exposure of axon terminals to amyloid beta. Alzheimers Dement. 2011, 7:S309-S310.
25. Taylor A.M., Blurton-Jones M., Rhee S.W., Cribbs D.H., Cotman C.W., Jeon N.L. Amicrofluidic culture platform for CNS axonal injury, regeneration and transport. Nat. Methods 2005, 2:599-605.
26. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am. J. Clin. Nutr. 1999, 69:842-856.
27. Wirths O., Weis J., Kayed R., Saido T.C., Bayer T.A. Age-dependent axonal degeneration in an Alzheimer mouse model. Neurobiol. Aging 2007, 28:1689-1699.
28. Yu J., Gattoni-Celli M., Zhu H., Bhat N.R., Sambamurti K., Gattoni-Celli S., Kindy M.S. Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AbetaPP Transgenic Mice. J.Alzheimers Dis. 2011, 25:295-307.
29. Xia P., Chen H.S., Zhang D., Lipton S.A. Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses. J.Neurosci. 2010, 30:11246-11250.